Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zai Lab (ZLAB) EBT (2020 - 2025)

Zai Lab (ZLAB) has disclosed EBT for 6 consecutive years, with -$53.3 million as the latest value for Q4 2025.

  • Quarterly EBT rose 34.7% to -$53.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$178.5 million through Dec 2025, up 30.59% year-over-year, with the annual reading at -$178.5 million for FY2025, 30.59% up from the prior year.
  • EBT hit -$53.3 million in Q4 2025 for Zai Lab, down from -$36.0 million in the prior quarter.
  • In the past five years, EBT ranged from a high of -$36.0 million in Q3 2025 to a low of -$233.1 million in Q1 2021.
  • Historically, EBT has averaged -$95.8 million across 5 years, with a median of -$81.0 million in 2024.
  • Biggest five-year swings in EBT: tumbled 387.15% in 2021 and later skyrocketed 70.77% in 2022.
  • Year by year, EBT stood at -$211.3 million in 2021, then surged by 70.77% to -$61.8 million in 2022, then tumbled by 54.49% to -$95.4 million in 2023, then increased by 14.4% to -$81.7 million in 2024, then soared by 34.7% to -$53.3 million in 2025.
  • Business Quant data shows EBT for ZLAB at -$53.3 million in Q4 2025, -$36.0 million in Q3 2025, and -$40.7 million in Q2 2025.